Neeraj Sharma

Array ( [id] => 5943496 [patent_doc_number] => 20110104116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'HSA-FREE FORMULATIONS OF INTERFERON-BETA' [patent_app_type] => utility [patent_app_number] => 13/004658 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12563 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104116.pdf [firstpage_image] =>[orig_patent_app_number] => 13004658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8650751 [patent_doc_number] => 20130036481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'USE OF PERLECAN DOMAIN V IN TREATING AMYLOIDOGENIC DISEASE' [patent_app_type] => utility [patent_app_number] => 13/519949 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14255 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13154493 [patent_doc_number] => 10093961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-09 [patent_title] => Methods for diagnosis of and predicting treatment efficacy of hormone receptor expressing tumors, cancers and neoplasias [patent_app_type] => utility [patent_app_number] => 12/975058 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 13011 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12975058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585721 [patent_doc_number] => 20130004543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'FIBRONECTIN: GROWTH FACTOR CHIMERAS' [patent_app_type] => utility [patent_app_number] => 13/511776 [patent_app_country] => US [patent_app_date] => 2010-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10575 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875293 [patent_doc_number] => 08962561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes' [patent_app_type] => utility [patent_app_number] => 13/509622 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 22 [patent_no_of_words] => 11525 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11574587 [patent_doc_number] => 09629827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Methods of treating vasodilatory shock' [patent_app_type] => utility [patent_app_number] => 12/942170 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10050 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10069536 [patent_doc_number] => 09107871 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'LHRH—antagonists in the treatment of fertility disorders' [patent_app_type] => utility [patent_app_number] => 12/941629 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2351 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12941629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10038166 [patent_doc_number] => 09078861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Use of a neuregulin to treat peripheral nerve injury' [patent_app_type] => utility [patent_app_number] => 12/904891 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 9067 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12904891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10830777 [patent_doc_number] => 08858939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Ectopic pregnancy treatment' [patent_app_type] => utility [patent_app_number] => 12/896094 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11323 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12896094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928930 [patent_doc_number] => 20110038889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR ALTERING CELL FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/895382 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 45136 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038889.pdf [firstpage_image] =>[orig_patent_app_number] => 12895382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823344 [patent_doc_number] => 08932828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins' [patent_app_type] => utility [patent_app_number] => 12/893764 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45098 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12893764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250405 [patent_doc_number] => 08614184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'HCG formulations for achieving weight loss' [patent_app_type] => utility [patent_app_number] => 12/888051 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3081 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12888051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993535 [patent_doc_number] => 20110015188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Treatment of Seasonal Conditions' [patent_app_type] => utility [patent_app_number] => 12/888172 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 33790 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015188.pdf [firstpage_image] =>[orig_patent_app_number] => 12888172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882533 [patent_doc_number] => 08969298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Liquid preparation of physiologically active peptide' [patent_app_type] => utility [patent_app_number] => 12/848638 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 17237 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12848638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482815 [patent_doc_number] => 20120282222 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-11-08 [patent_title] => 'Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 12/803873 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 13767 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12803873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482815 [patent_doc_number] => 20120282222 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-11-08 [patent_title] => 'Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 12/803873 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 13767 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12803873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421934 [patent_doc_number] => 08278422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof' [patent_app_type] => utility [patent_app_number] => 12/816475 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37737 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12816475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392583 [patent_doc_number] => 20100303884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'GROWTH FACTOR COMPLEXES AND MODULATION OF CELL MIGRATION AND GROWTH' [patent_app_type] => utility [patent_app_number] => 12/793386 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16869 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303884.pdf [firstpage_image] =>[orig_patent_app_number] => 12793386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581263 [patent_doc_number] => 20100291087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'METHOD OF TREATING FIBRPROLIFERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/780809 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17279 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291087.pdf [firstpage_image] =>[orig_patent_app_number] => 12780809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211173 [patent_doc_number] => 20120129780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'LACTOFERRIN AND BRAIN HEALTH AND PROTECTION IN ADULTS' [patent_app_type] => utility [patent_app_number] => 13/319630 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7910 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129780.pdf [firstpage_image] =>[orig_patent_app_number] => 13319630 [rel_patent_id] =>[rel_patent_doc_number] =>)